Covaxin has overall vaccine efficacy of 77.8%, claims Bharat Biotech in results from Phase 3 trials

Covaxin showed 65.2% protection against the Delta variant (B.1.617.2) of COVID-19. 

https://ift.tt/eA8V8J from https://ift.tt/3yhEwmL
by -
Tags

ليست هناك تعليقات:

إرسال تعليق

الاشتراك في: تعليقات الرسالة (Atom)

Punjab govt announces Rs 1 crore cash award to India men`s hockey team players from the state

Indian men's hockey team on Thursday morning created history at the Tokyo Olympics by winning a bronze, their first medal in 41 years fr...